An observational study in Research Participation, Recruitment and Engagement, sponsored by Johns Hopkins University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Johns Hopkins University · Observational
The HOPE (Hopkins Opportunities for Participant Engagement) Research Registry is a free and secure way for adults to learn about research studies at Johns Hopkins and find out about opportunities to participate. HOPE was created to help connect people who are interested in research with Johns Hopkins research teams conducting studies in many different health areas.
Adults age 18 or older who live in the United States may voluntarily join HOPE. To enroll, participants complete a short form that takes about 5 minutes and provide basic information about themselves and the types of research the participant may be interested in. Participants may receive information about new research studies, including studies related to the topics selected.
If a participant is interested in a study, the participant can choose to share contact information with the research team so the team can contact the participant directly. Joining HOPE does not mean that a person has to participate in any research study. Participation in HOPE is voluntary, there is no cost to join, and participants can update information or leave the registry at any time.
The HOPE (Hopkins Opportunities for Participant Engagement) Research Registry is a free, secure, disease-agnostic research recruitment registry designed to connect adults who are interested in research with research opportunities at Johns Hopkins University. The registry was established to provide a centralized resource where individuals can learn about Johns Hopkins research studies and, if interested, choose to be contacted by research teams.
HOPE is a dynamic registry, meaning that individuals may join on an ongoing basis and may update information or remove themselves from the registry at any time. The registry is intended to support recruitment for Johns Hopkins research studies that have appropriate Institutional Review Board (IRB) approval. HOPE is not itself a research study requiring participants to participate in a specific research intervention or procedure.
Participant information is securely stored and managed within the Johns Hopkins REDCap system. Access to identifiable information is limited to authorized personnel who are approved on the relevant IRB protocols and have completed required privacy training. Study teams using HOPE for recruitment receive limited access to information necessary to contact individuals who have expressed interest in the specific study.
The primary risk associated with joining HOPE is a potential loss of confidentiality of the personal information provided to the registry. Measures are in place to reduce this risk, including secure data storage, controlled access, required privacy training, and routine review of data access and security. There are no medical risks associated with participating in the registry.
Johns Hopkins University is the lead sponsor of 1,815 studies on the registry; 315 are open to participants now.
Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
The study population consists of adults age 18 or older who reside in the United States and are interested in learning about research opportunities and/or receiving information about research studies at Johns Hopkins. Participants may include Johns Hopkins patients as well as members of the general community.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HOPE is a research recruitment registry that connects adults interested in research with opportunities to learn about and participate in Johns Hopkins research studies. Participants provide demographic, contact, and research-interest information and may choose to share information with a research team when interested in a specific study. HOPE does not provide a treatment or other health interventions.
Number of individuals enrolled in the HOPE Research Registry
The number of individuals who voluntarily enroll in the HOPE Research Registry after completing the required consent process. Enrollment will be monitored as an ongoing measure of the reach and use of the registry.
Time frame: Ongoing throughout the duration of the registry, 5 years
Number of registry participants who share contact information with a research team
The number of HOPE participants who explicitly indicate interest in an IRB-approved research study and choose to share demographic and contact information with the study research team. This measure will be used to evaluate participant engagement with research opportunities provided through HOPE.
Time frame: Ongoing throughout the duration of the registry, 5 years
Plan to share: Yes — Individual participant data (IPD) collected through the HOPE Research Registry will not be routinely shared with external researchers. HOPE participants' demographic, contact, and research-interest information will only be shared with a Johns Hopkins research team when the participant explicitly indicates interest in a specific IRB-approved study and chooses to share their information with that research team. Shared information may include the participant's name, contact information, race, gender, ethnicity, and other relevant registry information provided by the participant.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Start Date: July 17, 2026 End Date: Ongoing IPD and supporting information will be available on an ongoing basis throughout the duration of the HOPE Research Registry. IPD will be shared with authorized Johns Hopkins research teams only when a participant explicitly indicates interest in an IRB-approved study and chooses to share their information.
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.